Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
Glycostem

Glycostem

Glycostem is a biotechnology developing cellular immunotherapies.

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

November 20, 2020
Glycostem Therapeutics announces the opening of a phase I/IIa trial for its lead product oNKord® for the treatment of AML patients.
2007
Glycostem was founded.

Patents

Further Resources

Title
Author
Link
Type
Date

News

Title
Author
Date
Publisher
Description
Glycostem Therapeutics
December 15, 2020
www.prnewswire.com:443
/PRNewswire/ -- Glycostem Therapeutics B.V., a leading clinical-stage company focused on the development of therapeutic off-the-shelf Natural Killer (NK)...
Glycostem Therapeutics
November 20, 2020
www.prnewswire.com:443
/PRNewswire/ -- Glycostem Therapeutics B.V., a leading clinical-stage company focused on the development of therapeutic off-the-shelf Natural Killer (NK)...
Golden logo
By using this site, you agree to our Terms & Conditions.